Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by Jack1016on Mar 03, 2020 10:22am

142 Views

Post# 30760555

RE:TH stock is sitting on rocketfuel

Rosmorduc wrote: Once ignition happens, it's to the stratosphere.

I can easily see TH as a 25$ stock.

Mr. Lvesque seems to recognize the importance of Trogarzo to TH and its potential. Yes, Trogarzo is the rocket fuel that can lift off the sp. Trogarzo might be just liquid fuel, while Taimed's next pdt can be solid fuel. TH must not miss it.

Bullboard Posts

Looking at: Is Taylor Swift the key to solving traffic in Toronto?